MX2014014769A - Pesario de cerclaje que contiene progesterona de liberacion prolongada, sostenida y continua, util para la prevencion de parto prematuro. - Google Patents

Pesario de cerclaje que contiene progesterona de liberacion prolongada, sostenida y continua, util para la prevencion de parto prematuro.

Info

Publication number
MX2014014769A
MX2014014769A MX2014014769A MX2014014769A MX2014014769A MX 2014014769 A MX2014014769 A MX 2014014769A MX 2014014769 A MX2014014769 A MX 2014014769A MX 2014014769 A MX2014014769 A MX 2014014769A MX 2014014769 A MX2014014769 A MX 2014014769A
Authority
MX
Mexico
Prior art keywords
pessary
progesterone
sustained
cerclage
prevent premature
Prior art date
Application number
MX2014014769A
Other languages
English (en)
Other versions
MX368212B (es
Inventor
Shu-Chen Chen
German Arzobindo Campos Perez
Original Assignee
Andromaco Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andromaco Lab filed Critical Andromaco Lab
Publication of MX2014014769A publication Critical patent/MX2014014769A/es
Publication of MX368212B publication Critical patent/MX368212B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Biological Depolymerization Polymers (AREA)

Abstract

Pesario de cerclaje que contiene progesterona distribuida homogéneamente en el cuerpo del pesario proporcionando una liberación prolongada, sostenida y continua, por un periodo de al menos 6 meses, donde el pesario está formado por elastómeros de dimetilsiloxano con mecanismo RTV (Room Temperature Vulcanization), la cantidad de progesterona está comprendida entre 20% a 30% p/p, respecto al peso del pesario y las proporciones de los polímeros que forman la matriz, se encuentra entre 6:1 a 14:1. El pesario de cerclaje es útil para la prevención de parto prematuro. La progesterona difunde a través del polímero en forma continua, sin alterar la forma e integridad del pesario, dado que el elastómero que forma la matriz polimérica utilizado en la presente invención, no es biodegradable. Esto garantiza que la forma del pesario se conserve intacta hasta el término de tratamiento.
MX2014014769A 2014-06-28 2014-06-28 Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, útil para la prevención de parto prematuro. MX368212B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2014/062691 WO2015198104A1 (es) 2014-06-28 2014-06-28 Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, útil para la prevención de parto prematuro

Publications (2)

Publication Number Publication Date
MX2014014769A true MX2014014769A (es) 2016-03-30
MX368212B MX368212B (es) 2019-09-24

Family

ID=54937437

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014769A MX368212B (es) 2014-06-28 2014-06-28 Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, útil para la prevención de parto prematuro.

Country Status (20)

Country Link
US (1) US9820994B2 (es)
EP (1) EP2982352B1 (es)
JP (1) JP6529583B2 (es)
KR (1) KR20170021929A (es)
CN (1) CN105392454B (es)
AR (2) AR098604A1 (es)
BR (1) BR112014030232A2 (es)
CA (1) CA2873222A1 (es)
CR (1) CR20160604A (es)
CY (1) CY1121245T1 (es)
DK (1) DK2982352T3 (es)
ES (1) ES2699003T3 (es)
HR (1) HRP20181794T1 (es)
HU (1) HUE040176T2 (es)
LT (1) LT2982352T (es)
MX (1) MX368212B (es)
PL (1) PL2982352T3 (es)
PT (1) PT2982352T (es)
SI (1) SI2982352T1 (es)
WO (1) WO2015198104A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102110132B1 (ko) * 2017-10-27 2020-05-13 고려대학교산학협력단 자궁경부 무력증에서 조산을 방지하기 위한 자궁경부 밴드 구조체
US11497647B2 (en) 2018-04-24 2022-11-15 Emory University Anatomical support systems, devices, and related methods
US11311409B2 (en) 2018-05-19 2022-04-26 Ashley Camille CRAFTON Hannah cervical cup
US11872395B2 (en) 2019-06-18 2024-01-16 Obstetric Solutions, Llc Pessary device and methods for preventing premature births
US12011602B2 (en) 2019-06-18 2024-06-18 Obstetric Solutions Llc Wireless power for pessary device
WO2021111385A2 (en) * 2019-12-06 2021-06-10 Prathima Chowdary Sustained release estrogen vaginal ring pessary for treatment of atrophy, cystitis and uterovaginal prolapse
KR102571791B1 (ko) * 2021-03-22 2023-08-28 가톨릭대학교 산학협력단 산모 맞춤형 조산 예방용 페서리 및 이의 제조방법

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US415991A (en) 1889-11-26 zipernowsky
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
DD114905A5 (es) * 1973-12-06 1975-09-05
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JP2590358B2 (ja) * 1988-03-01 1997-03-12 正雄 五十嵐 子宮内膜症治療用の子宮内又は膣内投与製剤
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
DE19606355A1 (de) * 1996-02-12 1997-08-14 Schering Ag Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung
FR2745180B1 (fr) * 1996-02-23 1998-05-07 Dow Corning Sa Procede de fabrication de dispositifs a liberation controlee
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
EP0981327B1 (en) * 1997-05-07 2002-11-06 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
AU1300799A (en) 1997-11-03 1999-05-24 Deschutes Medical Products, Inc. Pessary with medicated cartridge
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US20050197651A1 (en) * 2001-04-25 2005-09-08 Chen Hai L. Vaginal ring preparation and its application
US20040089308A1 (en) 2002-11-13 2004-05-13 Welch Robert A. Cervical ring to deliver medication
WO2004096151A2 (en) 2003-04-29 2004-11-11 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
BRPI0513141A (pt) 2004-07-09 2008-04-29 Population Council Inc composição para anel vaginal, e, processo de contracepção a longo prazo
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CA2713943C (en) * 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
FI20085277A0 (fi) * 2008-04-02 2008-04-02 Bayer Schering Pharma Oy Kohdunsisäinen järjestelmä
MX2012000948A (es) 2009-07-21 2012-02-28 Population Council Inc Anillo vaginal gradiente multicapas.
AU2011238710B2 (en) * 2010-03-28 2015-08-20 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) * 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CN103747765B (zh) 2011-06-06 2016-04-06 橡冠科学研究院 采用芯吸释放窗口的药物递送装置
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
DE102012009057A1 (de) 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente

Also Published As

Publication number Publication date
CY1121245T1 (el) 2020-05-29
ES2699003T3 (es) 2019-02-06
CN105392454B (zh) 2018-05-08
HRP20181794T1 (hr) 2018-12-28
US20160250229A1 (en) 2016-09-01
PT2982352T (pt) 2018-11-29
DK2982352T3 (en) 2018-11-26
HUE040176T2 (hu) 2019-02-28
CA2873222A1 (en) 2015-12-28
WO2015198104A1 (es) 2015-12-30
EP2982352A1 (en) 2016-02-10
JP6529583B2 (ja) 2019-06-12
LT2982352T (lt) 2018-11-12
AR098604A1 (es) 2016-06-01
AR122434A2 (es) 2022-09-14
SI2982352T1 (sl) 2018-12-31
CN105392454A (zh) 2016-03-09
US9820994B2 (en) 2017-11-21
CR20160604A (es) 2017-03-10
EP2982352B1 (en) 2018-10-03
MX368212B (es) 2019-09-24
JP2017524030A (ja) 2017-08-24
KR20170021929A (ko) 2017-03-02
PL2982352T3 (pl) 2019-01-31
EP2982352A4 (en) 2017-06-14
BR112014030232A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
MX368212B (es) Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, útil para la prevención de parto prematuro.
BR112017004493A2 (pt) composições de polímeros
MX2015016038A (es) Agente terapéutico y método de uso.
BR112017009656A2 (pt) dispositivo de molde ortopédico respirável aperfeiçoado e método de implementação de um sistema de moldagem ortopédica respirável em um membro do corpo
PH12016502015A1 (en) Anti-factor d antibody variants and uses thereof
BR112018014553A2 (pt) gaiola de confinamento de enxerto de osso helicoidal
BR112016008409A2 (pt) Uso de um agente inibidor de masp-2 que inibe a ativação de complemento dependente de masp-2
BR112015003094A8 (pt) dispositivo contraceptivo intrauterino
BR112013003002A2 (pt) composição contendo aditivo polar e agente quelante útil no hidroprocessamento de suprimentos hidrocarbonetos e método de sua produção e utilização
GB2550755A (en) Dual temperature curable silicone compositions, methods of manufacture, and articles prepared therefrom
BR112017008066A2 (pt) composição de polipropileno, processo para produção da composição de polipropileno, e, espuma extrusada.
CL2017001277A1 (es) Productos a base de sulfato de calcio resistentes al fuego
BR112015032665A8 (pt) ataduras ortopédicas de molde e tala com meio de endurecimento encapsulado e método
BR112017007171A2 (pt) processo para produção de pelotas de copolímeros macios
MX2018013346A (es) Goma de mascar con estevia.
MX2018004445A (es) Particulas coloidales para su uso en medicina.
Mekinian et al. Mothers' antiphospholipid antibodies during pregnancy and the relation to offspring outcome
BR112016029749A2 (pt) composições que compreendem cinamaldeído e zinco e métodos de uso de tais composições
BR112019025547A2 (pt) Formulações de cera que têm características de desprendimento melhoradas
BR112017019737A2 (pt) válvula de lingueta
BR112018006839A2 (pt) dispositivo intra-uterino recuperável
DOP2016000300A (es) Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, útil para la prevención de parto prematuro.
NI201600182A (es) Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, útil para la prevención de parto prematuro
Schooling Sexual selection as a driver of population health
IN2014MU00198A (es)

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: LABORATORIOS ANDROMACO, S.A. (EX INVERSIONES GRUCH

FG Grant or registration